Browse AMR Mutations
Explore antimicrobial resistance mutations from the literature
Explore antimicrobial resistance mutations from the literature
Overview
Antimalarial therapy selection for quinolone resistance among Escherichia coli in the absence of quinolone exposure, in tropical South America.
Mutations in gyrA and parC were associated with fluoroquinolone resistance.
Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia.
Mutations where in vitro MIC determination has demonstrated significantly elevated MICs of moxifloxacin
Integrating the Human and Animal Sides of Mycoplasmas Resistance to Antimicrobials.
Mutations in parC are associated with fluoroquinolone resistance.
Analysis of Neisseria gonorrhoeae and Mycoplasma genitalium from nucleic acid amplification test specimens, Nunavut region of Inuit Nunangat, Canada, 2020-2023.
Molecular detection of Mycoplasma genitalium in endocervical swabs and associated rates of macrolide and fluoroquinolone resistance in Hong Kong.
Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.
Estimation of antimicrobial resistance of Mycoplasma genitalium, Belgium, 2022.
Management of Mycoplasma genitalium infections - can we hit a moving target?
Resistance to moxifloxacin and other fourth-generation quinolones is mediated by mutations in the quinolone resistance determining regions (QRDR) of the parC gene, primarily in the hotspots in amino acid positions S83 and D87.
Endemic fluoroquinolone-resistant Salmonellaenterica serovar Kentucky ST198 in northern India.
Expansion of Salmonella Typhi clonal lineages with ampicillin resistance and reduced ciprofloxacin susceptibility in Eastern China.
Multicenter Clinical Evaluation of a Novel Multiplex Real-Time PCR (qPCR) Assay for Detection of Fluoroquinolone Resistance in Mycoplasma genitalium.
Antimicrobial resistance in Mycoplasma genitalium sampled from the British general population.
Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007-2014.
Mutations in the QRDR of the parC gene were detected in 54/266 (20.3%) specimens.
Bacterial resistance studies using in vitro dynamic models: the predictive power of the mutant prevention and minimum inhibitory antibiotic concentrations.
Single nucleotide substitution in the quinolone-resistance determining region (QRDR) of parC
Mycoplasma genitalium in Symptomatic Male Urethritis: Macrolide Use Is Associated With Increased Resistance.
Mutations in parC gene associated with fluoroquinolone resistance
Clinical Performance of Three Commercial Molecular Diagnostic Assays for the Detection of Fluoroquinolone Resistance-Associated Mutations in Mycoplasma genitalium.
Mutations in the parC gene were associated with fluoroquinolone resistance.
Prevalence of fluoroquinolone resistance-associated mutations in Mycoplasma genitalium among clients of two sexual health centres in the Netherlands: a cross-sectional study.
Mycoplasma genitalium antibiotic resistance-associated mutations in genital and extragenital samples from men-who-have-sex-with-men attending a STI clinic in Verona, Italy.
clinically relevant
Global analysis on the mutations associated with multidrug-resistant urogenital mycoplasmas and ureaplasmas infection: a systematic review and meta-analysis.
mutations in parC gene associated with fluoroquinolone resistance
Mycoplasma genitalium in Singapore is associated with Chlamydia trachomatis infection and displays high macrolide and Fluoroquinolone resistance rates.
mutations in parC associated with fluoroquinolone resistance
In vitro activity of the first-in-class triazaacenaphthylene gepotidacin alone and in combination with doxycycline against drug-resistant and -susceptible Mycoplasma genitalium.
Rapid Detection of Antimicrobial Resistance in Mycoplasma genitalium by High-Resolution Melting Analysis with Unlabeled Probes.
Mutations in the parC gene are responsible for fluoroquinolone resistance in Mycoplasma genitalium.
Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance.
Mycoplasma genitalium parC mutations confers resistance to Moxifloxacin; CARD accession: CARD:3004630
Mycoplasma genitalium Antimicrobial Resistance in Community and Sexual Health Clinic Patients, Auckland, New Zealand.
Mutations in codon 83 of parC are associated with resistance; therefore, the mutation at T249A was presumed to confer fluoroquinolone resistance. The importance of polymorphisms in parC at C184T and C356T is uncertain.
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research